|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
108,000,000 |
Market
Cap: |
N/A |
Last
Volume: |
5,721,727 |
Avg
Vol: |
2,596,545 |
52
Week Range: |
$73.89 - $73.89 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Porter Steven Bryant |
Chief Medical Officer |
|
2011-03-09 |
4 |
AS |
$44.59 |
$312,151 |
D/D |
(7,000) |
57,729 |
|
- |
|
Porter Steven Bryant |
Chief Medical Officer |
|
2011-03-09 |
4 |
OE |
$15.40 |
$107,800 |
D/D |
7,000 |
64,729 |
|
- |
|
Bradford Williamson Z III |
SVP-Clinical Science |
|
2011-03-09 |
4 |
AS |
$44.59 |
$267,568 |
D/D |
(6,000) |
66,648 |
|
- |
|
Bradford Williamson Z III |
SVP-Clinical Science |
|
2011-03-09 |
4 |
OE |
$12.74 |
$76,440 |
D/D |
6,000 |
72,648 |
|
- |
|
Armstrong Marianne |
SVP Ch Reg & Drug Safety Off |
|
2011-03-09 |
4 |
AS |
$44.59 |
$329,421 |
D/D |
(7,387) |
57,646 |
|
- |
|
Armstrong Marianne |
SVP Ch Reg & Drug Safety Off |
|
2011-03-09 |
4 |
OE |
$15.40 |
$113,760 |
D/D |
7,387 |
65,033 |
|
- |
|
Welch Daniel G |
Chairman, CEO and President |
|
2011-03-03 |
4 |
AS |
$39.69 |
$1,746,263 |
D/D |
(44,000) |
272,995 |
|
- |
|
Seiwert Scott |
SVP, Rsearch & Technical Dev. |
|
2011-03-02 |
4 |
D |
$37.17 |
$100,694 |
D/D |
(2,709) |
56,265 |
|
- |
|
Simon Howard Allan |
SVP-Human Resources |
|
2011-03-02 |
4 |
D |
$37.17 |
$84,748 |
D/D |
(2,280) |
44,696 |
|
- |
|
Steele Robin Joan |
SVP, GC, Secretary |
|
2011-03-02 |
4 |
D |
$37.17 |
$122,587 |
D/D |
(3,298) |
78,610 |
|
- |
|
Porter Steven Bryant |
Chief Medical Officer |
|
2011-03-02 |
4 |
D |
$37.17 |
$119,985 |
D/D |
(3,228) |
57,729 |
|
- |
|
Bradford Williamson Z III |
SVP-Clinical Science |
|
2011-03-02 |
4 |
D |
$37.17 |
$119,985 |
D/D |
(3,228) |
66,648 |
|
- |
|
Armstrong Marianne |
SVP Ch Reg & Drug Safety Off |
|
2011-03-02 |
4 |
D |
$37.17 |
$119,985 |
D/D |
(3,228) |
57,646 |
|
- |
|
Hodgman John |
SVP-Finance & CFO |
|
2011-03-02 |
4 |
D |
$37.17 |
$122,475 |
D/D |
(3,295) |
61,268 |
|
- |
|
Armstrong Marianne |
SVP Ch Reg & Drug Safety Off |
|
2011-02-23 |
4 |
AS |
$35.94 |
$265,509 |
D/D |
(7,387) |
60,874 |
|
- |
|
Armstrong Marianne |
SVP Ch Reg & Drug Safety Off |
|
2011-02-23 |
4 |
OE |
$15.40 |
$113,760 |
D/D |
7,387 |
68,267 |
|
- |
|
Porter Steven Bryant |
Chief Medical Officer |
|
2011-02-23 |
4 |
AS |
$35.94 |
$251,549 |
D/D |
(7,000) |
60,957 |
|
- |
|
Porter Steven Bryant |
Chief Medical Officer |
|
2011-02-23 |
4 |
OE |
$15.40 |
$107,800 |
D/D |
7,000 |
67,957 |
|
- |
|
Bradford Williamson Z III |
SVP-Clinical Science |
|
2011-02-23 |
4 |
AS |
$35.94 |
$215,642 |
D/D |
(6,000) |
69,876 |
|
- |
|
Bradford Williamson Z III |
SVP-Clinical Science |
|
2011-02-23 |
4 |
OE |
$12.74 |
$76,440 |
D/D |
6,000 |
75,874 |
|
- |
|
Kabakoff David S |
Director |
|
2011-01-28 |
4 |
OE |
$11.33 |
$745,590 |
D/D |
52,002 |
52,002 |
|
- |
|
Healy James |
Director |
|
2010-12-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,499 |
4,150 |
|
- |
|
Welch Daniel G |
Chairman, CEO and President |
|
2010-12-17 |
4 |
AS |
$29.15 |
$14,797,310 |
D/D |
(507,663) |
316,995 |
|
- |
|
Welch Daniel G |
Chairman, CEO and President |
|
2010-12-17 |
4 |
OE |
$10.11 |
$7,061,811 |
D/D |
500,141 |
824,658 |
|
- |
|
Steele Robin Joan |
SVP, GC, Secretary |
|
2010-12-06 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
81,908 |
|
- |
|
772 Records found
|
|
Page 14 of 31 |
|
|